Hafslund Nycomed's Omniscan MRI contrast agent has been certifiedfor marketing in Japan, the Oslo, Norway, company reported thismonth. Nycomed said that Omniscan will be launched by DaiichiPharmaceutical, Nycomed's Japanese licensee, as soon as
Hafslund Nycomed's Omniscan MRI contrast agent has been certified
for marketing in Japan, the Oslo, Norway, company reported this
month. Nycomed said that Omniscan will be launched by Daiichi
Pharmaceutical, Nycomed's Japanese licensee, as soon as final
price approval is granted by Japanese authorities. Nycomed added
that it has submitted an application for marketing approval in
Japan for Visipaque, its third-generation x-ray contrast agent.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.